Back in 2015, Sivan et al. explored the stimulatory role of Bifidobacterium (including Bifidobacterium breve, Bifidobacterium longum, and Bifidobacterium adolescentis) in assisting the anti-tumor response elicited by anti-PD-L1 mAbs (20). Here, CD274 is linked to neoplasm.